These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6404440)

  • 41. Hepatitis B vaccine: implications for dental personnel.
    Cooley RL; Lubow RM
    J Am Dent Assoc; 1982 Jul; 105(1):47-9. PubMed ID: 7050210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study on the immuno-effects and influencing factors of Chinese hamster ovary (CHO) cell hepatitis B vaccine among adults, under different dosages].
    Zhang W; Lin CY; Han LL; Li LQ; Gao P; Lin H; Gong XH; Huang F; Tang YQ; Ma JX; Zhang HY; Wang C; Yang P; Li H; Sun MP; He X; Pang XH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):767-70. PubMed ID: 21162840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subcutaneous administration of inactivated hepatitis B vaccine by automatic jet injection.
    Lemon SM; Scott RM; Bancroft WH
    J Med Virol; 1983; 12(2):129-36. PubMed ID: 6619812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatitis B vaccine trial in healthy adults - an immunogenicity study (author's transl)].
    Zachoval R; Frösner G; Deinhardt F
    MMW Munch Med Wochenschr; 1981 Oct; 123(40):1506-8. PubMed ID: 6795461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine.
    Dupont J; Altclas J; Lepetic A; Lombardo M; Vázquez V; Salgueira C; Seigelchifer M; Arndtz N; Antunez E; von Eschen K; Janowicz Z
    Vaccine; 2006 Nov; 24(49-50):7167-74. PubMed ID: 16884836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
    Krairittichai U; Sethakarun S
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Passive/active immunization against hepatitis B.
    Zachoval R; Jilg W; Lorbeer B; Schmidt M; Deinhardt F
    J Infect Dis; 1984 Jul; 150(1):112-7. PubMed ID: 6235294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Active immunization against hepatitis B].
    Wildgrube HJ; Classen M; von Lohr R; Kurth R; Brede HD
    Dtsch Med Wochenschr; 1984 Feb; 109(7):246-50. PubMed ID: 6230216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
    Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
    Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-exposure active immunoprophylaxis of spouses of acute viral hepatitis B patients.
    Roumeliotou-Karayannis A; Papaevangelou G; Tassopoulos N; Richardson SC; Krugman S
    Vaccine; 1985 Mar; 3(1):31-4. PubMed ID: 3890398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Active pre-exposure immunisation against hepatitis B virus: immunogenicity of hepatitis B vaccine in healthy Thai adults and children.
    Pongpipat D; Suvatte V; Assateerawatts A; Bhethraratt S
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):63-5. PubMed ID: 2956961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.